Back to Search
JARED ROSENSTOCK, MD, DMD
MD, DMD
Oral and Maxillofacial Surgery (Dentist)
NPI: 1669889119Individual
Specialties, Licenses & Credentials
Oral and Maxillofacial Surgery (Dentist)Primary
Dentist — Oral and Maxillofacial Surgery
Code: 1223S0112X
060116(NY)
Research & Publications (20)
The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy.
PMID 18438718·Int Urol Nephrol·2008
2-rct
Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
PMID 12631361·Kidney Int·2003
8-other
Fludarabine treatment of cryoglobulinemic glomerulonephritis.
PMID 12200818·Am J Kidney Dis·2002
5-case
Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus.
PMID 19383032·Diabetes Obes Metab·2009
4-observational
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
PMID 19650754·Curr Med Res Opin·2009
2-rct
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
PMID 19515413·Lancet·2009
4-observational
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
PMID 19526210·Diabetologia·2009
4-observational
Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing.
PMID 19592625·Diabetes Care·2009
2-rct
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.
PMID 19609501·Diabetologia·2009
2-rct
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.
PMID 18678610·Diabetes Care·2008
4-observational
SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes.
PMID 18678611·Diabetes Care·2008
2-rct
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
PMID 18796160·BMC Neurol·2008
4-observational
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
PMID 18204830·Diabetologia·2008
4-observational
Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.
PMID 18596429·Neurosurgery·2008
8-other
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes.
PMID 18355324·Diabetes Obes Metab·2008
4-observational
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
PMID 18458145·Diabetes Care·2008
2-rct
Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
PMID 18535196·Diabetes Care·2008
2-rct
Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
PMID 18269437·Int J Clin Pract Suppl·2008
6-review
Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes.
PMID 18201206·Diabetes Obes Metab·2008
2-rct
Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.
PMID 18093207·Diabetes Obes Metab·2008
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1438 3rd Ave Apt 9A
New York, NY 10028 - Phone
- (215) 410-7354
Quick Facts
- NPI
- 1669889119
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile